BGI-Shenzhen And Complete Genomics, Inc. Receive CFIUS Clearance For BGI-Shenzhen's Proposed Acquisition Of Complete Genomics, Inc.

BGI-Shenzhen (“BGI”) and Complete Genomics, Inc. (“Complete”) announced recently that they have obtained clearance from the Committee on Foreign Investment in the United States (“CFIUS”) regarding BGI’s proposed acquisition of Complete pursuant to the previously announced Agreement and Plan of Merger, dated as of September 15, 2012, among BGI, Beta Acquisition Corporation and Complete.

BGI’s financial advisor is Citi, and its legal counsel is O’Melveny & Myers LLP. Complete’s financial adviser is Jefferies & Company, and its legal counsel is Latham & Watkins LLP.